Viewing Protocol Section

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section

Study NCT00101959
Ignite Creation Date: 2024-05-05 @ 11:40 AM
Last Modification Date: 2024-10-26 @ 9:11 AM
Study NCT ID: NCT00101959
Protocol Section: NCT00101959
Start Identification Module Data
Expand Identification Module Data
Brief Title: Implementation Study of Treatment Optimization Recommendations on Relapsing-Remitting Multiple Sclerosis RR MS Subjects
Official Title: An Implementation Study of Treatment Optimization Recommendations Comparing Subjects Continuing Treatment With IFN-ß-1a 30 Mcg qw IM Avonex or Glatiramer Acetate 20 mg qd SC Copaxone to Those Randomized to IFN-ß-1a 44 Mcg Tiw SC Rebif in a Multicenter Study of Subjects With Relapsing Remitting Multiple Sclerosis Currently on Disease-Modifying Therapy
Acronym: None
Organization: EMD Serono
Organization Class: INDUSTRY
Organization Study ID: 25277
Start Status Module Data
Status Verified Date: 2013-08
Overall Status: WITHDRAWN
Study First Submit Date:
Study First Submit QC Date:
Last Update Submit Date:
Status:
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: EMD Serono
Lead Sponsor Class: INDUSTRY
Lead Sponsor: EMD Serono
Start Oversight Module Data
Description Module:
Study Last Update Post Date Type(Status Module):
Attachment: Upload